Viracta Therapeutics' Series B - IV Round

Viracta Therapeutics raised a round of funding on March 12, 2012.

Viracta Therapeutics, formerly Hemaquest Pharmaceuticals, is a clinical-stage drug development company focused on advancing a proprietary viral activation therapy platform to address cancers associate…

Articles about Viracta Therapeutics' Series B - IV Round: